Literature DB >> 24282763

Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction.

Megha Agarwal1, Chrisandra Shufelt, Puja K Mehta, Edward Gill, Daniel S Berman, Debiao Li, Behzad Sharif, Ning Li, C Noel Bairey Merz, Louise E J Thomson.   

Abstract

UNLABELLED: Women with myocardial ischemia without obstructive coronary artery disease (CAD) often have microvascular coronary dysfunction (MCD). Traditional cardiac risk factors (RFs) contribute modestly to MCD detected by invasive coronary reactivity testing (CRT). Cardiac magnetic resonance imaging (CMRI) is an emerging noninvasive technique used to evaluate MCD. We evaluated RFs related to CMRI myocardial perfusion in women with MCD. 53 women with CRT confirmed MCD underwent adenosine stress and rest CMRI (1.5 Tesla). The myocardial perfusion reserve index (MPRI) was calculated (Pie Medical) with lower MPRI meaning less perfusion reserve. Relationships between RFs and MPRI were examined. The mean age was 54±10 years with a mean body mass index (BMI) of 26.2±4.2. The mean MPRI was 1.63±0.39. Hypertension, dyslipidemia, elevated BMI, and post-menopausal status were inversely related to MPRI, while ever smoking, age, family history of CAD, history of irregular menses, and history of menopausal hormone therapy (MHT) or oral contraceptive (OC) use were not. Dyslipidemia and BMI remained significant independent predictors of MPRI. Regression modeling demonstrated that the RFs of dyslipidemia, obesity, hypertension, family history of CAD, and history of irregular menses explained 27% of the observed MCD variance.
CONCLUSIONS: In conclusion, impaired MPRI measured by CMRI is related to dyslipidemia and elevated BMI in women with MCD. These results suggest traditional RFs contribute modestly to MCD; a larger cohort of women with MCD should be examined to confirm and extend these observations. The impact of traditional CAD RF modification strategies, including optimal medical therapy, should be explored as MCD treatment targets.

Entities:  

Keywords:  Microvascular coronary dysfunction (MCD); cardiac risk factors (RFs); myocardial perfusion reserve

Year:  2013        PMID: 24282763      PMCID: PMC3839214          DOI: 10.3978/j.issn.2223-3652.2013.08.01

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  25 in total

1.  Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Janet Wei; Puja K Mehta; B Delia Johnson; Bruce Samuels; Saibal Kar; R David Anderson; Babak Azarbal; John Petersen; Barry Sharaf; Eileen Handberg; Chrisandra Shufelt; Kamlesh Kothawade; George Sopko; Amir Lerman; Leslee Shaw; Sheryl F Kelsey; Carl J Pepine; C Noel Bairey Merz
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

2.  Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  S E Reis; R Holubkov; J S Lee; B Sharaf; N Reichek; W J Rogers; E G Walsh; A R Fuisz; R Kerensky; K M Detre; G Sopko; C J Pepine
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

3.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Authors:  P A Kaufmann; T Gnecchi-Ruscone; M di Terlizzi; K P Schäfers; T F Lüscher; P G Camici
Journal:  Circulation       Date:  2000-09-12       Impact factor: 29.690

5.  Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study.

Authors:  Gretchen L Gierach; B Delia Johnson; C Noel Bairey Merz; Sheryl F Kelsey; Vera Bittner; Marian B Olson; Leslee J Shaw; Sunil Mankad; Carl J Pepine; Steven E Reis; William J Rogers; Barry L Sharaf; George Sopko
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

Review 6.  Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

Authors:  Leslee J Shaw; C Noel Bairey Merz; Carl J Pepine; Steven E Reis; Vera Bittner; Sheryl F Kelsey; Marian Olson; B Delia Johnson; Sunil Mankad; Barry L Sharaf; William J Rogers; Timothy R Wessel; Christopher B Arant; Gerald M Pohost; Amir Lerman; Arshed A Quyyumi; George Sopko
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

Review 7.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

8.  Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Gregory O von Mering; Christopher B Arant; Timothy R Wessel; Susan P McGorray; C Noel Bairey Merz; Barry L Sharaf; Karen M Smith; Marian B Olson; B Delia Johnson; George Sopko; Eileen Handberg; Carl J Pepine; Richard A Kerensky
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

9.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

Authors:  Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

10.  Angina with "normal" coronary arteries: sex differences in outcomes.

Authors:  Karin H Humphries; Aihua Pu; Min Gao; Ronald G Carere; Louise Pilote
Journal:  Am Heart J       Date:  2007-12-19       Impact factor: 4.749

View more
  7 in total

Review 1.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

2.  Current Diagnostic and Therapeutic Strategies in Microvascular Angina.

Authors:  Bryn Mumma; Nathalie Flacke
Journal:  Curr Emerg Hosp Med Rep       Date:  2015-03

3.  Beyond equality, women require extra care in cardiovascular imaging.

Authors:  Laura Evangelista; Samia Massalha; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-13       Impact factor: 10.057

4.  Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study.

Authors:  Haider Aldiwani; Michael D Nelson; Behzad Sharif; Janet Wei; T Jake Samuel; Nissi Suppogu; Odayme Quesada; Galen Cook-Wiens; Edward Gill; Lidia S Szczepaniak; Louise E J Thomson; Balaji Tamarappoo; Anum Asif; Chrisandra Shufelt; Daniel Berman; C Noel Bairey Merz
Journal:  Vessel Plus       Date:  2022-03-05

Review 5.  The role of stress cardiac magnetic resonance in women.

Authors:  Andrea Cardona; Karolina M Zareba; Subha V Raman
Journal:  J Nucl Cardiol       Date:  2016-07-25       Impact factor: 5.952

6.  Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.

Authors:  Kade Birkeland; Raj M Khandwalla; Ilan Kedan; Chrisandra L Shufelt; Puja K Mehta; Margo B Minissian; Janet Wei; Eileen M Handberg; Louise Ej Thomson; Daniel S Berman; John W Petersen; R David Anderson; Galen Cook-Wiens; Carl J Pepine; C Noel Bairey Merz
Journal:  JMIR Res Protoc       Date:  2017-12-20

7.  A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.

Authors:  C Noel Bairey Merz; Eileen M Handberg; Chrisandra L Shufelt; Puja K Mehta; Margo B Minissian; Janet Wei; Louise E J Thomson; Daniel S Berman; Leslee J Shaw; John W Petersen; Garrett H Brown; R David Anderson; Jonathan J Shuster; Galen Cook-Wiens; André Rogatko; Carl J Pepine
Journal:  Eur Heart J       Date:  2015-11-27       Impact factor: 35.855

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.